Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting-Reference-Cited by-同舟云学术

Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting

Author:

Thomas Lynn N.¹,Merrimen Jennifer²³,Bell David G.³,Rendon Ricardo³,Goffin Vincent⁴,Too Catherine K. L.¹⁵

Affiliation:

1. Departments of Biochemistry & Molecular Biology; Faculty of Medicine; Dalhousie University; Halifax NS Canada

2. Departments of Pathology; Faculty of Medicine; Dalhousie University; Halifax NS Canada

3. Departments of Urology; Faculty of Medicine; Dalhousie University; Halifax NS Canada

4. Inserm U845, Centre de Recherche Croissance et Signalisation, Faculté de Médecine; University Paris Descartes; Paris France

5. Departments of Obstetrics & Gynecology; Faculty of Medicine; Dalhousie University; Halifax NS Canada

Publisher

Wiley

Subject

Urology,Oncology

Reference55 articles.

2. Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells;Zegarra-Moro;Cancer Res,2002

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献